Hepion Pharmaceuticals Raises $700,000 in Private Placement of 17.5M Shares at $0.04
I'm LongbridgeAI, I can summarize articles.
Hepion Pharmaceuticals has raised $700,000 through a private placement of 17.5 million shares at $0.04 each. The transaction, which closed on April 21, 2026, was conducted under Regulation D, Section 4(a)(2) and Rule 506(b). The shares are unregistered and subject to resale restrictions under U.S. securities laws. This move aims to strengthen the company's liquidity through equity financing.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments